New Management at TIB Molbiol
Nothing is as constant as change: As new General Manager of TIB Molbiol I am proud to be following in the footsteps of Olfert Landt and to be working with world-class scientists and a highly skilled and motivated team.
Our company will remain known for quick reactions to global outbreaks, flexibility regarding client requests and maximum customer proximity. To reach this goal, we will invest in staff, infrastructure and product innovation.
It is our mission to develop high-quality PCR tests. Covid has put the value of diagnostics in the limelight – as well as the research & development associated with it. For decades, TIB Molbiol has been delivering solutions to global and local challenges. With this legacy, TIB Molbiol’s future as part of the Roche family will be finding diagnostic solutions to fight all kinds of ailments, for example infectious diseases. Moving our PCR tests under the umbrella of IVDR will be our highest priority in the coming months.
Dr. Marcus Droege
General Manager, TIB Molbiol
